The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Research-Grade Proteins Market During The Forecast Period 2026–2030?
The research-grade proteins market size has experienced rapid expansion in recent years. It is projected to increase from $1.33 billion in 2025 to $1.61 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 20.8%. Historically, this growth can be attributed to the expansion of academic life sciences research, the growing utilization of proteins in molecular biology experiments, intensified biopharmaceutical R&D activities, the presence of recombinant protein expression systems, and increased funding for basic biomedical research.
The research-grade proteins market is projected to experience substantial growth in the upcoming years, with its size anticipated to reach $3.19 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.6%. This expansion during the forecast period is primarily fueled by an escalating focus on precision medicine research, a heightened demand for protein-based drug targets, advancements in cell and gene therapy research, the broadening application of proteins in structural biology, and an increase in research activity outsourcing by pharmaceutical firms. Key trends expected in this period encompass a rising need for high-purity proteins in drug discovery, the expanding use of recombinant proteins in cell and molecular biology studies, increased adoption of research-grade proteins in immunology and oncology research, the proliferation of protein-based assays and functional studies, and a stronger preference for custom and application-specific proteins.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp
Which Major Factors Are Driving The Expansion Of The Research-Grade Proteins Market?
An increasing volume of clinical trials is anticipated to boost the expansion of the research-grade proteins market. These trials are defined as investigative studies examining the safety and efficacy of novel medical therapies, procedures, or equipment in human subjects. The surge in clinical trials can be attributed to progress in medical research, the prevalence of diseases, evolving regulations, patient requirements, and investments from the industry. Research-grade proteins are instrumental in clinical trials, functioning as crucial resources for developing biomarkers and assays, identifying drug targets, ensuring quality control, and providing reference standards, thereby guaranteeing the precision and trustworthiness of experimental findings. As an illustration, the Association of the British Pharmaceutical Industry (ABPI), an organization situated in the UK, reported in December 2024 that the quantity of pharmaceutical industry trials initiated in the UK saw an increase for the second year running, moving from 411 in 2022 to 426 in 2023. Consequently, the expanding volume of clinical trials is stimulating the advancement of the research-grade proteins market.
What Market Segments Are Evaluated Within The Research-Grade Proteins Market?
The research-grade proteins market covered in this report is segmented –
1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells
3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses
Subsegments:
1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor
2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies
3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens
5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases
6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers
7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline
8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins
What Industry Trends Are Redefining The Research-Grade Proteins Market?
Leading companies in the research-grade proteins market are prioritizing the creation of innovative solutions, such as high-purity, animal-origin-free recombinant proteins, to enhance consistency, safety, and performance in advanced cell and gene therapy workflows. These high-purity, animal-origin-free recombinant proteins are laboratory-produced without any animal-derived components and are meticulously purified to very high standards, ensuring consistency, safety, and reliability for both research and therapeutic applications. As an illustration, in October 2025, Qkine Ltd., a manufacturing company based in the UK, launched a new line of Cell Therapy Grade recombinant proteins specifically engineered to meet the strict requirements of cell therapy research, process development, and GMP manufacturing. These high-purity, animal-origin-free proteins exhibit low endotoxin levels and minimal host cell contaminants, and they are produced using defined manufacturing standards complete with comprehensive regulatory documentation. Their dependable performance supports seamless scalability, from early-stage research to GMP clinical workflows. Designed for advanced applications including CAR-T, iPSC differentiation, and ex vivo gene editing, these regulatory-ready proteins contribute to accelerating therapy development while simultaneously reducing associated risks.
Who Are The Top Market Participants Influencing The Research-Grade Proteins Market?
Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)
Read the full research-grade proteins market report here:
https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report
Which Region Currently Holds The Largest Share Of The Research-Grade Proteins Market?
North America was the largest region in the research-grade proteins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Research-Grade Proteins Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp
Browse Through More Reports Similar to the Global Research-Grade Proteins Market 2026, By The Business Research Company
Research Grade Proteins Market Report 2026
https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report
Protein Assays Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report
Protein Engineering Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-engineering-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model